Ka-Kei Ho

1.2k total citations
8 papers, 978 citations indexed

About

Ka-Kei Ho is a scholar working on Molecular Biology, Geriatrics and Gerontology and Genetics. According to data from OpenAlex, Ka-Kei Ho has authored 8 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Geriatrics and Gerontology and 1 paper in Genetics. Recurrent topics in Ka-Kei Ho's work include Sirtuins and Resveratrol in Medicine (3 papers), FOXO transcription factor regulation (2 papers) and Autophagy in Disease and Therapy (1 paper). Ka-Kei Ho is often cited by papers focused on Sirtuins and Resveratrol in Medicine (3 papers), FOXO transcription factor regulation (2 papers) and Autophagy in Disease and Therapy (1 paper). Ka-Kei Ho collaborates with scholars based in United Kingdom, Denmark and Finland. Ka-Kei Ho's co-authors include Eric W.‐F. Lam, Stephen S. Myatt, R. Charles Coombes, Matthew J. Fuchter, Paolo Di Fruscia, Chwan‐Deng Hsiao, Chun‐Yuan Chen, Barrie Peck, Lara J. Monteiro and Jun Wang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Ka-Kei Ho

8 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ka-Kei Ho United Kingdom 8 595 292 288 172 168 8 978
Pei Y. Liu Australia 15 1.4k 2.3× 260 0.9× 792 2.8× 194 1.1× 190 1.1× 18 1.7k
Nail Fatkhutdinov United States 13 806 1.4× 83 0.3× 187 0.6× 339 2.0× 93 0.6× 15 1.1k
Rumela Chakrabarti United States 11 742 1.2× 217 0.7× 244 0.8× 504 2.9× 267 1.6× 12 1.2k
Nilotpal Roy United States 17 682 1.1× 76 0.3× 160 0.6× 386 2.2× 105 0.6× 20 1.1k
Meejeon Roh United States 14 407 0.7× 53 0.2× 115 0.4× 254 1.5× 57 0.3× 21 740
Gerald Chu United States 5 924 1.6× 71 0.2× 195 0.7× 234 1.4× 52 0.3× 14 1.1k
Adam M. LaBaff United States 8 576 1.0× 66 0.2× 376 1.3× 355 2.1× 69 0.4× 8 894
Baohua Sun United States 20 893 1.5× 44 0.2× 117 0.4× 268 1.6× 52 0.3× 41 1.2k
Laura Zannini Italy 16 817 1.4× 71 0.2× 203 0.7× 335 1.9× 68 0.4× 24 1.0k

Countries citing papers authored by Ka-Kei Ho

Since Specialization
Citations

This map shows the geographic impact of Ka-Kei Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka-Kei Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka-Kei Ho more than expected).

Fields of papers citing papers by Ka-Kei Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka-Kei Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka-Kei Ho. The network helps show where Ka-Kei Ho may publish in the future.

Co-authorship network of co-authors of Ka-Kei Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ka-Kei Ho. A scholar is included among the top collaborators of Ka-Kei Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka-Kei Ho. Ka-Kei Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fruscia, Paolo Di, Ka-Kei Ho, Mattaka Khongkow, et al.. (2012). The discovery of novel 10,11-dihydro-5H-dibenz[b,f]azepine SIRT2 inhibitors. MedChemComm. 3(3). 373–373. 21 indexed citations
2.
Heathcote, Dean A., et al.. (2012). A Deficiency in Nucleoside Salvage Impairs Murine Lymphocyte Development, Homeostasis, and Survival. The Journal of Immunology. 188(8). 3920–3927. 17 indexed citations
3.
Ho, Ka-Kei, Victoria A. McGuire, Chuay-Yeng Koo, et al.. (2011). Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin. Journal of Biological Chemistry. 287(2). 1545–1555. 117 indexed citations
4.
Horimoto, Yoshiya, Johan Hartman, Julie Millour, et al.. (2011). ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast Cancer. American Journal Of Pathology. 179(3). 1148–1156. 33 indexed citations
5.
Peck, Barrie, Chun‐Yuan Chen, Ka-Kei Ho, et al.. (2010). SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2. Molecular Cancer Therapeutics. 9(4). 844–855. 371 indexed citations
6.
Vianello, Fabrizio, Federica Villanova, Veronica Tisato, et al.. (2010). Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica. 95(7). 1081–1089. 128 indexed citations
7.
Myatt, Stephen S., Jun Wang, Lara J. Monteiro, et al.. (2009). Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer. Cancer Research. 70(1). 367–377. 284 indexed citations
8.
Ho, Ka-Kei, Alexandra Anderson, Erika Rosivatz, et al.. (2007). Identification of Cyclin A2 as the Downstream Effector of the Nuclear Phosphatidylinositol 4,5-Bisphosphate Signaling Network. Journal of Biological Chemistry. 283(9). 5477–5485. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026